Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

21 results
Display

A striking flail chest: a rare manifestation of intestinal disease

Liu S, Ruan GC, You Y, Qian JM, Li J

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The optimal time to perform an ophthalmic examination of patients with inflammatory bowel disease

Biancardi , Troncoso L, de Moraes Jr HV, Zaltman C

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Gastrointestinal histoplasmosis: a case series from a non-endemic region in North India

Mandavdhare HS, Shah J, Prasad KK, Agarwala R, Suri V, Kumari S, Dutta U, Sharma V

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Acute pancreatitis associated with indigo naturalis in pediatric severe Crohn’s disease

Kim HA, Suh HR, Kang B, Choe BH, on behalf of Crohn's and Colitis Association in DaeguGyeongbuk (CCAiD)

The incidence of inflammatory bowel disease (IBD) is rapidly increasing worldwide. Indigo naturalis is known to have an antiinflammatory effect. Indigo naturalis has been traditionally used in the treatment of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical features and outcomes in spontaneous intramural small bowel hematoma: cohort study and literature review

Kang EA, Han SJ, Chun J, Lee HJ, Chung H, Im JP, Kim SG, Kim JS, Yoon H, Shin CM, Park YS, Kim N, Lee DH, Jung HC

BACKGROUND/AIMS: Spontaneous intramural small bowel hematoma (SISBH) is an extremely rare complication of anticoagulant or antiplatelet therapy. We assessed the clinical characteristics and outcomes of patients with SISBH according to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinicopathological feature and treatment outcome of patients with colorectal laterally spreading tumors treated by endoscopic submucosal dissection

Jeong YH, Lee J, Kim SW, Seo GS, Kim HS, Joo YE

BACKGROUND/AIMS: Endoscopic submucosal dissection (ESD) is an advanced technique that can be used to treat precancerous and early colorectal neoplasms by facilitating en bloc resection regardless of tumor size. In...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The current capacity and quality of colonoscopy in Korea

Choi JH, Cha JM, Yoon JY, Kwak MS, Jeon JW, Shin HP

BACKGROUND/AIMS: Little is known for the capacity and quality of colonoscopy, and adherence to colonoscopy surveillance guidelines in Korea. This study aimed to investigate the present and potential colonoscopic capacity,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Health-related quality of life of patients with inflammatory bowel disease in Singapore

Min Ho PY, Hu W, Lee YY, Gao C, Tan YZ, Cheen HH, Wee HL, Lim TG, Ong WC

BACKGROUND/AIMS: Inflammatory bowel disease (IBD) is associated with considerable impairment of patients’ health-related quality of life (HRQoL). Knowledge of factors that significantly affect IBD patients’ HRQoL can contribute to better...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Long-term prognosis of Japanese patients with biologic-naïve Crohn’s disease treated with anti-tumor necrosis factor-α antibodies

Moroi R, Endo K, Yamamoto K, Naito T, Onodera M, Kuroha M, Kanazawa Y, Kimura T, Kakuta Y, Masamune A, Kinouchi Y, Shimosegawa T

BACKGROUND/AIMS: Few reports have described the long-term treatment outcomes of the anti-tumor necrosis factor-α antibody for Japanese Crohn’s disease (CD) patients. The aim of this study was to evaluate them...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Randomized, crossover questionnaire survey of acceptabilities of controlled-release mesalazine tablets and granules in ulcerative colitis patients

Yagisawa K, Kobayashi , Ozaki R, Okabayashi S, Toyonaga T, Miura M, Hayashida , Saito E, Nakano M, Matsubara , Hisamatsu , Hibi T

BACKGROUND/AIMS: Oral mesalazine is an important treatment for ulcerative colitis (UC), and non-adherence to mesalazine increases the risk of relapse. Controlled-release (CR) mesalazine has 2 formulations: tablets and granules. The...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy of fecal microbiota therapy in steroid dependent ulcerative colitis: a real world intention-to-treat analysis

Sood A, Mahajan R, Juyal G, Midha V, Grewal CS, Mehta V, Singh A, Joshi MC, Narang V, Kaur K, Sidhu H

BACKGROUND/AIMS: Four high-quality randomized controlled trials have proven the efficacy of fecal microbiota transplantation (FMT) in active ulcerative colitis (UC). We assessed the efficacy of FMT in a real-world setting...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Vitamin D deficiency is associated with disease activity in patients with Crohn’s disease

Ko KH, Kim YS, Lee BK, Choi JH, Woo YM, Kim JY, Moon JS

BACKGROUND/AIMS: Previous data suggest that vitamin D has a significant role in inflammatory bowel disease (IBD). We investigated the incidence of vitamin D deficiency in Korean patients with IBD and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hypoalbuminemia as a risk factor for thromboembolic events in inflammatory bowel disease inpatients

Imbrizi MR, Magro DO, Secundo TD, Cunha-Silva M, Kotze PG, Montes CG, Almeida JR, Cabral VL

BACKGROUND/AIMS: Inflammatory bowel disease (IBD) are chronic entities characterized by local and systemic inflammation and may be associated with thrombosis. The aim of this study was to identify the prevalence...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide populationbased study

Yen HH, Weng MT, Tung CC, Wang YT, Chang YT, Chang CH, Shieh MJ, Wong JM, Wei SC

BACKGROUND/AIMS: Incidences of inflammatory bowel disease (IBD), ulcerative colitis (UC), and Crohn’s disease (CD), have been increasing in Asia. In this study, we report the relevant clinical characteristics and determined...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Improving the quality of care for inflammatory bowel disease

Ye BD, Travis S

Great strides have been achieved in the development of quality-of-care measures and standards for inflammatory bowel disease (IBD) over the last decade. The central structural component of care in IBD...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Current new challenges in the management of ulcerative colitis

Fukuda T, Naganuma M, Kanai T

Ulcerative colitis (UC) is a chronic inflammatory condition of the gastrointestinal tract. Although the cause of UC is postulated to be multifactorial in nature, including genetic predisposition, epithelial barrier defects,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Successful transition from pediatric to adult care in inflammatory bowel disease: what is the key?

Kim J, Ye BD

The incidence of pediatric-onset inflammatory bowel disease (IBD) is on the rise, accounting for up to 25% of IBD cases. Pediatric IBD often has extensive bowel involvement with aggressive and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical aspects and treatments for pediatric inflammatory bowel diseases

Moon JS

The incidence of pediatric inflammatory bowel disease (IBD) is increasing worldwide, especially in the developing countries. It differs from adult disease in clinical manifestations, especially with regard to genetic predisposition...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recent advance in very early-onset inflammatory bowel disease

Shim JO

Recent studies on pediatric inflammatory bowel disease (IBD) have revealed that early-onset IBD has distinct phenotypic differences compared with adult-onset IBD. In particular, very early-onset IBD (VEO-IBD) differs in many...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Multi-session fecal microbiota transplantation using colonoscopy has favorable outcomes for the treatment of steroid-dependent ulcerative colitis

Cho YS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr